The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapiesShogo Kumagai, Hiroyoshi Nishikawa, Hitomi Nishinakamura et al.|Nature Immunology|2020Cited by 810
Blockade of EGFR improves responsiveness to PD-1 blockade in <i>EGFR</i> -mutated non–small cell lung cancerEri Sugiyama, Hiroyoshi Nishikawa, Yosuke Togashi et al.|Science Immunology|2020Cited by 285